Glenmark sells gynaecology biz for Rs 115 Cr
22 January 2020 | News
The business has been sold to the new entity incorporated by True North called Intergrace
image credit- shuttershock.com
Mumbai based pharmaceutical company Glenmark Pharmaceuticals has sold its gynaecology business in India and Nepal to private equity firm True North, formerly known as India Value Fund Advisors or IVFA, for Rs 115 crore.
The business has been sold to the new entity incorporated by True North called Intergrace.
Back in August 2018, Glenmark had transferred its orthopaedic and pain management business in India and Nepal to True North's new entity Intergrace.
